The columnaris disease treatment market is projected to grow from USD 777.0 million in 2026 to USD 1,662.0 million by 2036, at a CAGR of 7.9%. Oxytetracycline will dominate with a 34.0% market share, while warm-water fish will lead the applications segment with a 58.0% share.